SCHEMBL443578

SCHEMBL443578

CCC(C)O[PH](=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2142959 0.93
SCHEMBL5146455 0.84
SCHEMBL6065332 0.84
SCHEMBL27934464 0.80
SCHEMBL13885715 0.80
SCHEMBL15302821 0.80 CTSK (0.33)
SCHEMBL11811827 0.79
SCHEMBL3617067 0.79 RNPEP (0.32)
SCHEMBL975493 0.78 TSHR (0.36)
SCHEMBL13885718 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 305 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119980346-A Polymer electrolyte material photoelectric anode and preparation method and application thereof 大连理工大学 2025-05-13 CN claimed
CN-117303992-A Preparation method of polyfunctional group substituted chiral sulfoxide compound 厦门大学 2023-12-29 CN claimed
CN-110279684-B Use of formyl peptide receptor 2 agonists for the treatment of ocular inflammatory diseases 阿勒根公司 2023-02-28 CN claimed
WO-2022237884-A1 ANTIBODY DRUG CONJUGATE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 清华大学 2022-11-17 WO claimed
CN-110402516-B Polymer electrolyte and method for producing same 株式会社LG化学 2022-06-21 CN claimed
US-10995104-B2 Catalysts for reversing formaldehyde adducts and crosslinks ROCHE MOLECULAR SYSTEM, INC. (US) 2021-05-04 US claimed
CN-105254667-A Functionalized oil-soluble ionic liquid and preparing method and application thereof LANZHOU CHEM PHYS INST 2016-01-20 CN claimed
US-8153791-B2 substituted pyrimidine compoundssuch as 4-amino-6-(3-chloro-4-fluoro-phenylamino)-pyrimidine-5-carbaldehyde O-methyl oxime, used for treating, preventing or ameliorating a chronic or acute protein kinase mediated diseasea, disorders or conditions JANSSEN PHARMACEUTICA N.V. (BE) 2012-04-10 US claimed
US-20100168170-A1 Piperidinones Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2010-07-01 US claimed
EP-2137150-A1 PIPERIDINONES USEFUL IN THE TREATMENT OF INFLAMMATION Biolipox AB (SE) 2009-12-30 EP claimed
US-20070270425-A1 SUBSTITUTED PYRIMIDINYL OXIME KINASE INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2007-11-22 US claimed
CN-100347151-C Novel aminobenzophenones LEO PHARMA AS (DK) 2007-11-07 CN claimed
US-20060199886-A1 Metal phosphate sols, metal nanoparticles, metal-chalcogenide nanoparticles, and nanocomposites made therefrom APS LABORATORY 2006-09-07 US claimed
CN-1561327-A Novel aminobenzophenones LEO PHARMA AS (DK) 2005-01-05 CN claimed
US-20040138487-A1 Bisphospholane ligands with metals for hydrogenation catalysts for enantiomorphs HOGE GARRETT STEWART 2004-07-15 US claimed
US-20030073868-A1 Non-C2-symmetric bisphosphine ligands as catalysts for asymmetric hydrogenation WARNER-LAMBERT COMPANY 2003-04-17 US claimed
US-20020143214-A1 Synthesis of non-C2-symmetric bisphosphine ligands as catalysts for asymmetric hydrogenation HOGE GARRETT STEWART (US) 2002-10-03 US claimed
CN-1202891-A New quinoxalindione derivatives, their preparation and use in medicaments SCHERING AG (DE) 1998-12-23 CN claimed
EP-0309491-A1 ANTIVIRAL AGENTS SRI INTERNATIONAL (US) 1989-04-05 EP claimed
WO-1988005438-A1 ANTIVIRAL AGENTS SRI INTERNATIONAL (US) 1988-07-28 WO claimed